InMode (INMD) Depreciation & Amortization (CF) (2018 - 2026)

InMode (INMD) posted quarterly Depreciation & Amortization (CF) of $175000.0 for Q1 2026, up 0.57% year-on-year from $174000.0 in Q1 2025, and up 0.57% on a QoQ basis from $174000.0 in Q4 2025.

InMode (INMD) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $175000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 0.57% year-over-year to $175000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 5.56% YoY) and the FY2025 annual result came in at $695000.0, down 4.53% from the prior year.
  • Depreciation & Amortization (CF) improved to $175000.0 in Q1 2026 per INMD's latest filing, from $174000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for INMD reached as high as $248000.0 in Q4 2024 and fell as low as $122000.0 in Q4 2023.
  • A 5-year average of $170647.1 and a median of $174000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 44.04% — and 2024, when it jumped 103.28%.
  • Year by year, Depreciation & Amortization (CF) stood at $218000.0 in 2022, then sank by 44.04% to $122000.0 in 2023, then soared by 103.28% to $248000.0 in 2024, then slipped by 29.84% to $174000.0 in 2025, then gained by 0.57% to $175000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $175000.0, $174000.0, and $156000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 175,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 175,000.00
Mar 31, 2026 175,000.00
Dec 31, 2025 174,000.00
Dec 31, 2025 174,000.00
Sep 30, 2025 156,000.00
Sep 30, 2025 156,000.00
Jun 30, 2025 191,000.00
Jun 30, 2025 191,000.00
Mar 31, 2025 174,000.00
Mar 31, 2025 174,000.00
Dec 31, 2024 248,000.00
Dec 31, 2024 248,000.00
Sep 30, 2024 138,000.00
Sep 30, 2024 138,000.00
Jun 30, 2024 177,000.00
Jun 30, 2024 177,000.00
Mar 31, 2024 165,000.00
Mar 31, 2024 165,000.00
Dec 31, 2023 122,000.00
Dec 31, 2023 122,000.00